| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79d6a911fdd8dd42cee380eddc3a99b6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2020-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d63c2c5c80778159aaa4ab2c59abf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f86b435c37a45d92c8965a011edc9db0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8232a5bb572057b1fb7e720f1fbbc072 |
| publicationDate |
2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111686084-A |
| titleOfInvention |
Application of a berberine hydrochloride oryzanol tablet in the treatment of diabetes |
| abstract |
The invention provides a berberine oryzanol hydrochloride tablet and its application in the treatment of diabetes. The berberine oryzanol hydrochloride tablet is formed by mixing and compressing a certain proportion of modified berberine oryzanol granules and other auxiliary materials. The modified particles are composed of a drug, a surfactant and a dispersant, and the modified particles can well improve the solubility of berberine hydrochloride and oryzanol, and improve the dissolution rate and bioavailability of the drug. The tablet achieves a good effect of treating diabetes through drug compatibility, reasonable prescription and preparation process. Berberine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021258683-A1 |
| priorityDate |
2020-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |